114 related articles for article (PubMed ID: 9868838)
1. Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.
Migliori GB; Khomenko AG; Punga VV; Ambrosetti M; Danilova I; Ribka LN; Grzemska M; Sawert H; Raviglione MC
Bull World Health Organ; 1998; 76(5):475-83. PubMed ID: 9868838
[TBL] [Abstract][Full Text] [Related]
2. Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group.
Migliori GB; Ambrosetti M; Besozzi G; Farris B; Nutini S; Saini L; Casali L; Nardini S; Bugiani M; Neri M; Raviglione MC
Bull World Health Organ; 1999; 77(6):467-76. PubMed ID: 10427931
[TBL] [Abstract][Full Text] [Related]
3. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of an alternative tuberculosis management strategy for permanent farm dwellers in South Africa amidst health service contraction.
Clarke M; Dick J; Bogg L
Scand J Public Health; 2006; 34(1):83-91. PubMed ID: 16449048
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of the russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia.
Jacobs B; Clowes C; Wares F; Polivakho V; Lyagoshina T; Peremitin G; Banatvala N
Int J Tuberc Lung Dis; 2002 May; 6(5):396-405. PubMed ID: 12019915
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.
Vassall A; Bagdadi S; Bashour H; Zaher H; Maaren PV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1083-90. PubMed ID: 12546116
[TBL] [Abstract][Full Text] [Related]
7. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.
Floyd K; Skeva J; Nyirenda T; Gausi F; Salaniponi F
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S29-37. PubMed ID: 12971652
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. [Cost benefit of detection and treatment patients with tuberculosis in Ivanovo region, Russian Federation].
Khomenko AG; Punga VV; Rybka LN; Grishina TA; Migliori DB; Ambrosetti M; Ravilyone M; Grzemska M; Stoiunin MB; Danilova ID; Filippova LV
Probl Tuberk; 1998; (3):9-13. PubMed ID: 9691679
[TBL] [Abstract][Full Text] [Related]
10. Primary multidrug-resistant tuberculosis--Ivanovo Oblast, Russia, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Aug; 48(30):661-4. PubMed ID: 10488782
[TBL] [Abstract][Full Text] [Related]
11. [Current malaria situation in the Republic of Kazakhstan].
Bismil'din FB; Shapieva ZhZh; Anpilova EN
Med Parazitol (Mosk); 2001; (1):24-33. PubMed ID: 11548308
[TBL] [Abstract][Full Text] [Related]
12. Cost and cost-effectiveness of a public-private mix project in Kannur District, Kerala, India, 2001-2002.
Ferroussier O; Kumar MK; Dewan PK; Nair PK; Sahu S; Wares DF; Laserson K; Wells C; Granich R; Chauhan LS
Int J Tuberc Lung Dis; 2007 Jul; 11(7):755-61. PubMed ID: 17609050
[TBL] [Abstract][Full Text] [Related]
13. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
[TBL] [Abstract][Full Text] [Related]
14. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of community health workers in tuberculosis control in Bangladesh.
Islam MA; Wakai S; Ishikawa N; Chowdhury AM; Vaughan JP
Bull World Health Organ; 2002; 80(6):445-50. PubMed ID: 12132000
[TBL] [Abstract][Full Text] [Related]
16. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.
Sinanovic E; Floyd K; Dudley L; Azevedo V; Grant R; Maher D
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S56-62. PubMed ID: 12971655
[TBL] [Abstract][Full Text] [Related]
17. Latent tuberculosis infection in children: a call for revised treatment guidelines.
Finnell SM; Christenson JC; Downs SM
Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis control in Bangladesh: success of the DOTS strategy.
Kumaresan JA; Ahsan Ali AK; Parkkali LM
Int J Tuberc Lung Dis; 1998 Dec; 2(12):992-8. PubMed ID: 9869115
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM
Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453
[TBL] [Abstract][Full Text] [Related]
20. Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda.
Okello D; Floyd K; Adatu F; Odeke R; Gargioni G
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S72-9. PubMed ID: 12971657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]